Peptidoglycan (PGN) is ubiquitous in nearly all bacterial species. The PGN sacculus protects the cells against their own internal turgor making PGN one of the most important targets for antibacterial treatment. Within the last sixty years PGN composition has been intensively studied by various methods. The breakthrough was the application of HPLC technology on the analysis of muropeptides. However, preparation of pure PGN relied on a very time consuming method of about one week. We established a purification protocol for both Gram-positive and Gram-negative bacteria which can be completely performed in plastic reaction tubes yielding pure muropeptides within 24 hours. The muropeptides can be analyzed by UPLC-MS, allowing their immediate determination. This new rapid method provides the feasibility to screen PGN composition even in high throughput, making it a highly useful tool for basic research as well as for the pharmaceutical industry.
shorter 5 . However, it still relies on washing in an ultracentrifuge thereby limiting the amounts of samples that can be prepared in parallel.
PGN research has experienced a revival within the last decade. Even PGN from bacteria like Chlamydiae, which had long been thought to not contain a PGN sacculus, was now successfully isolated and analyzed 6 . In addition, it had been shown, that growth conditions 7, 8 as well as various antibiotics as b-lactams and daptomycin affect PGN composition [9] [10] [11] . To test PGN composition of different bacteria and under various conditions, a faster analysis method was needed. One which allows to test several conditions in parallel and which can also be applied to bacteria that are not easily grown in high amounts.
We established a purification protocol which can be completely performed in 2 ml reaction tubes, allowing the isolation of up to 48 samples in parallel or even in 96 well plates, yielding pure muropeptides in 24 hours. The muropeptides can be subsequently analyzed by UPLC. This reduces the amount of sample needed and the analysis time from about three hours (HPLC) to 70 min per sample. In addition, the LC conditions were adapted to mass spectrometry (MS) with suitable solvents so that the whole PGN can be directly analyzed by UPLC-MS. This allows for muropeptide determination without first collecting and desalting LC peaks and results in a complete PGN mapping. Taken together, the whole procedure is reduced from about two weeks to 24 hours. Furthermore, this fast isolation method also makes it much easier to obtain larger amounts of PGN which can be used to collect special muropeptides that can then be tested for their ability to stimulate the immune system 12 .
Results and Discussion Peptidoglycan isolation. All steps are performed in 2 ml reaction tubes with a U-shaped bottom. A detailed step-to-step protocol is given in the online method. The method is based on the isolation of PGN by boiling in 1 M NaCl. In the case of some Gram-positive strains we experienced that NaCl treatment is not sufficient. A 0.25% sodium dodecylsulfate (SDS) solution in 0.1 M Tris/HCl (pH 6.8) was then used instead. The SDS has to be washed out again thoroughly. A test for residual SDS is available and should be performed 13 . The resulting cell walls are washed with water and broken into smaller fragments by sonication. DNAse, RNAse, and trypsin are used to digest residual nucleic acids as well as cell wall bound proteins. The enzymes are inactivated by boiling and the cell walls are washed again with water. Treatment with 1 N HCl releases bound wall teichoic acids (WTA) or other glycophosphates. Higher concentrations of HCl must be avoided, as they result in clumping of the sample. In former protocols 4 , 48% HF was used to release WTA, but comparison of PGN treated with HCl or with HF showed no significant differences (see Fig. S1 ). Washing the pellet until the pH is neutral results in pure PGN that can be digested by cell wall hydrolases. In our case the PGN was digested with mutanolysin for 16 hours at 37uC shaking.
Peptidoglycan analysis by UPLC. Prior to UPLC analysis the MurNAc residues of the muropeptides are reduced into NAcmuraminitol by sodium borohydrate (NaBH 4 ). Otherwise, mutarotation of the non-reduced glycan end would result in double peaks. Analysis is performed by UPLC (or HPLC) using trifluoracetic acid (TFA) and a methanol gradient from 5 to 30% (for Gram-positives) or from 0 to 30% (for Gram-negatives) in 70 min. TFA is an ion pairing agent that forms an ion bond with the muropeptides resulting in a good separation of mixed analyts. As TFA is volatile it can also be used for MS analysis. However, it reduces the sensitivity of the mass spectrometer which might require extra washing after use. After testing several different columns, the reversed phase UPLC column CSH C18, 130Å , 1.7 mm, 2.1 mm 3 100 mm of Waters was best suited for our needs.
Peptidoglycan mapping by UPLC-MS. The samples can also be directly analyzed by UPLC-MS. We used a Synapt G2 mass spectrometer coupled to a Waters Acquity H-class and operated in positive ESI mode with a scan range from 50-2,000. The data was analyzed by MassLynx. As an example for PGN isolation by this new method, UPLC analysis and MS-mapping are presented in Fig. 1 and Fig. 2 . For Gram-positives we used Staphylococcus aureus (S. aureus) SA113 14 and for Gram-negatives Escherichia coli (E. coli) Nissle 1917 15 .
Exemplary analysis of S. aureus SA113 by UPLC and UPLC-MS. The methicillin sensitive S. aureus strain SA113 was grown over night in BM medium. We isolated its PGN and analyzed it by UPLC as well as by UPLC-MS. This enabled us to directly determine the masses of all muropeptide peaks we got by UPLC separation. The total ion current (TIC) chromatogram obtained by UPLC-MS was almost identical to the UV pattern of UPLC alone with two exceptions: 1) Retention time of the peaks in the quaternary UPLC was about 1 min longer than in the binary UPLC-MS system. Therefore, in tables 1 and S1 only the TIC retention times are given.
2) The signal of some muropeptides, that turned out to be O-acetylated, were stronger in the TIC than in the UV (e.g. peaks 9 in Fig. 1a and b) . The UV chromatogram of the UPLC as well as the TIC chromatogram of the MS show the expected pattern as it had been published before for the methicillin resistant S. aureus COL by de Jonge et al. in 1992 4, 16 . By coupling UPLC to MS we could directly determine the masses and subsequently the potential structures of almost all peaks. The obtained masses verified that the main peaks contained the expected muropeptides starting with the monomeric peak 5 (Penta(Gln)Gly 5 ) which is the basic structure of all muropeptides. Peaks 11, 15, 16, 17 and 18 were composed of this basic structure cross-linked by the Gly 5 interpeptide bridge into dimers, trimers, tetramers, pentamers, and hexamers, respectively (for general structures see Fig. 3 ). This proved that our substantially shortened purification method as well as the adaption of UPLC-MS is working properly. Tab. 1 gives an overview on the muropeptides of the main peaks that we detected in our analysis which had already been determined before 4, 17 . The complete results of our PGN mapping of S. aureus SA113 is given in Tab. S1. All structures were drawn by ChemDrawUltra 13.0 (PerkinElmer), which automatically calculated the mass of the molecule and the proposed sum formula. The latter is given. As can be judged by the peak forms in the UPLC chromatogram, most peaks are composed of several muropeptides. While all of them have the same basic structure (MurNac-GlcNac with stem peptide and Gly 5 interpeptide bridge), several modifications occur, which will be discussed in detail:
The lengths of the stem peptides are variable. Monomeric stem peptides of S. aureus are mostly composed of the following five amino acids (L-Ala -D-iGln -L-Lys-D-Ala -D-Ala) with the DiGln resulting from the amidation of the original D-iGlu 18, 19 . These structures are called ''Pentas''. Cross-linking of several muropeptides by their interpeptide bridges forms multimeric muropeptides with normally one Penta and several Tetras, as the last D-Ala is cleaved off during the transpeptidation reaction. The resulting muropeptides are called ''Penta-Tetra n ''. However, several of the higher cross-linked muropeptides had lost the last D-Ala on the Penta stem peptide shortening it to a Tetra, forming ''Tetra n '' muropeptides. No further degradation into tripeptides was observed suggesting that S. aureus does not possess an L,D-carboxypeptidase activity.
In S. aureus, the D-iGlu at position two of the stem peptide is almost quantitatively amidated resulting in D-iGln 18, 19 . However, some muropeptides still harbor the original D-iGlu. While these non-amidated forms have been published to have a shorter retention time than their amidated counterparts 18 , in our system they had longer retention times. This might be due to the different column used for analysis. The length and the composition of the interpeptide bridge varies. Gly numbers that are not a multiple of 5 indicate that this very muropeptide was originally part of a bigger molecule but had been reorganized within the PGN sacculus. For example we found monomeric muropeptides with 6, 7, 8 or 9 Gly residues instead of 5, and dimeric muropeptides with 6, 7, 8 or 9 Gly residues instead of 10. In Tab. 1 and Tab. S1 the sum of all Gly residues of each muropeptide is given. In addition, two muropeptides contained Ala in exchange for one Gly in the interpeptide bridge. Muropeptides harboring various numbers of Gly residues or Ala in their interpeptide bridge have been published before 4 .
There also occur changes in the saccharide moiety. Several muropeptides had lost one GlcNAc residue. In rare cases we also found an additional GlcNAc residue, which resulted in a muropeptide with a trisaccharide, but we did not observe the addition of an extra MurNac. In table S1 the addition or loss of a GlcNAc residue is given as 11 or 21 respectively.
Even though O-acetylation had been thought to be lost during acidic treatment, we detected that most of the small peak groups, as well as some of the peak shoulders, both of which had not been analyzed so far, were composed of acetylated muropeptides. Even treatment with HF did not result in a loss of the O-acetylated muropeptides (see Fig. S1 ). As an example, peak 9 contained only the O- in table 2 and table S2 including molecule composition and proposed sum formula. Each muropeptide contains one to six stem-peptides, each consisting of L-Ala -D-Gln -L-Lys -D-Ala (-D-Ala). The amount of Gly molecules building the interpeptide bridges is given as the sum of all Gly residues present in each muropeptide. In rare cases one Gly is replaced by an Ala. The last column refers to the original reference of the respective muropeptide. Even though we cannot exclude that part of the O-acetylation is lost during isolation, a change of the respective peaks would be an indication for changes in the O-acetylation grade and could be useful to screen for possible mutants or for drugs affecting O-acetylation. A very small amount of MurNac residues seemed not to be completely reduced to NAc-muraminitol. This also resulted in longer retention times compared to the reduced counterparts.
Exemplary analysis of E. coli Nissle 1917 by UPLC and UPLC-MS. As an example for Gram-negative bacteria we grew E. coli Nissle 1917 overnight in LB medium and isolated its PGN. The PGN was digested by mutanolysin and analyzed by UPLC and UPLC-MS (Fig. 2) . Again, the UV pattern was very similar to the TIC chromatogram and we could determine the masses of most muropeptide peaks. The masses we found resulted in proposed muropeptide structures that are in accordance with the ones previously published by Glauner 3 (Tab. 2). The complete analysis is given in Tab. S2.
We found the expected monomeric muropeptides with the Tri and the Tetra stem-peptide (peak 1 and 4, respectively), the dimeric muropeptides Tetra-Tri and Tetra-Tetra (peaks 7 and 8, respectively) as well as in small amounts the trimeric muropeptide TetraTetra-Tetra (peak 10). (For a schematic drawing of the Gramnegative muropeptides see Fig. 3b ). Interestingly, for the Tetra, the Tetra-Tri and the Tetra-Tetra, we always got two peaks in the TIC chromatogram but only one in the UV chromatogram. We fragmented the respective peaks and they seem to be stereo-isomers as in all three cases closely related fragmentation spectra with different relative fragment peak intensities were obtained. Fig. S2 gives the exemplary fragmentation of peaks 8a and 8b, both being the Tetra-Tetra muropeptide. We did not get any hints for mDap-mDap-crosslinking, as it had been seen in strain E. coli W7 3 . The monomeric peak 3 in the TIC chromatogram is not in correlation with any peak of the UV chromatogram. Vice versa, the UV chromatogram has two unlabeled peaks, for which we cannot assign a muropeptide. Peak 3 of the TIC chromatogram contains 4 muropeptides (Tab. S2) with two of them being already known from the Glauner analysis 3 , the Di and the Penta-Gly(5) monomer. While these two peaks in the Glauner analysis have a higher retention time than the Tetra, they have a shorter retention time when analyzed with our conditions. The same is seen for Tetra-Penta-Gly(5) (peak 6) which in our system elutes before the Tetra-Tri and not after it.
With these few exceptions the elution profile of the E. coli muropeptides under our conditions is the same as already known. We also found one anhydro Tetra-Tetra muropeptide (peak 11), but we did not find any structures still containing lysine and arginine, which would be remnants from Braun's Lipoprotein 21 . Instead we found masses corresponding to muropeptides which had lost the GlcNAc moiety (Tab. S2). These are probably features of the strain we used. As expected, in all muropeptides with a Penta stem-peptide, the amino acid in position five is a Gly, as the last D-Ala is cleaved off by the D,D-carboxypeptidase penicillin-binding protein (PBP) 5 22 . We did obtain masses for the peaks between minutes 14 and 21, but they did not fit any muropeptide structures and are therefore not given.
Conclusion
We have presented here a very quick method for PGN isolation with additional analysis on UPLC-MS all within 24 hours. This method is suitable for high throughput screening of various bacterial strains or growth conditions, as it is performed in either 2 ml plastic reaction tubes or even in microtiter plates. With this new procedure we mapped the whole PGN of S. aureus SA113 up to the hexameric cross-linked muropeptide. In addition to the already known muropeptide structures of the prevalent peaks we have also presented masses and structures for the so far unidentified smaller peak groups in between. As an example for Gram-negatives we analyzed the PGN of E. coli Nissle 1917 and corroborated former publications.
Methods
The protocols will also be provided at www.nature.com/protocolexchange. Bacterial strains. S. aureus SA113 14 and E. coli Nissle 1917 15 .
Cell growth. The cells were grown in their respective medium to the needed OD. Basic medium (BM) for S. aureus consisted of Soy Peptone (10 g; Plato), Yeast Extract (5 g; Deutsche Hefewerke), NaCl (5 g; Carl-Roth), Glucose (1 g; Carl Roth) and K 2 HPO 4 (1 g; Applichem). Deionized water was added to a final volume of 1 liter and pH was adjust to 7.2. LB medium for E. coli consisted of Peptone (10 g; Plato), Yeast Extract (5 g; Deutsche Hefewerke) and NaCl (5 g; Carl Roth). Deionized water was added to a final volume of 1 liter and pH was adjust to 7.2.
Reagents. Unless otherwise stated, all reagents were bought from Sigma-Aldrich.
Midipreparation for UPLC/MS or HPLC/MS analysis. This protocol results in sample amounts suitable for several analyses. From 2 ml of culture of OD 578 < 10 about 300 ml purified PGN are gained. Spin down 2 ml of an overnight culture in a 2 ml microcentrifuge tube (Eppendorf) for 5 min at 10,000 rpm. Alternatively: Spin down 2 3 2 ml of a culture with a lower OD. Resuspend the pellet in 1 ml solution A (1 M sodium chloride) and boil the suspension for 20 minutes at 100uC in a heating block. [D CRITICAL STEP 1: Sometimes, NaCl treatment is not sufficient for peptidoglycan isolation from the cells. Use 0.25% SDS solution in 0.1 M Tris/HCl (pH 6.8) instead. SDS has to be washed out thoroughly after boiling. Make sure the samples are boiling at 100uC. Bad isolation results are mostly caused by too low heat.] Spin down the suspension (5 min at 10,000 rpm), wash it at least twice with 1.5 ml ddH 2 O and resuspend the pellet in 1 ml ddH 2 O. Put the sample to a sonifier waterbath for 30 minutes. Add 500 ml of solution B (15 mg/ml DNase and 60 mg/ml RNase in 0.1 M TRIS/HCl, pH 6.8) and incubate for 60 minutes at 37uC in a shaker. Add 500 ml of solution C (50 mg/ml trypsin in ddH 2 O) and incubate for additional 60 minutes at the same conditions. To inactivate the enzymes boil the suspension for 3 minutes at 100uC in a heating block, then spin the sample down (5 min at 10,000 rpm) and wash it once with 1 ml ddH 2 O. To release WTA resuspend the pellet in 500 ml of 1 M HCl (ready-to-use solution from Applichem) and incubate for 4 h at 37uC in a shaker. Spin down the suspension (5 min at 10,000 rpm) and wash with ddH 2 O until the pH is 5-6. Afterwards, resuspend the pellet in 100-250 ml digestion buffer (12.5 mM sodium dihydrogen-phosphate, pH 5.5) to an OD 578 of 3.0 and add 1/10 volume of mutanolysin solution (5.000 U/ml of mutanolysin in ddH 2 O). [D CRITICAL STEP 2: If OD 578 is too high the sample is too concentrated. Therefore, the digestion with mutanolysin might be disturbed. Measurement of OD is tricky, because peptidoglycan sinks to the bottom. Mix the suspension carefully with a pipette and measure OD rapidly.] Then incubate the sample for 16 h at 37uC (150 rpm shaking). Inactivate mutanolysin by boiling (100uC) for 3 min. Spin the sample down (5 min at 10,000 rpm) and use the supernatant. Before applying the sample to the UPLC system, MurNAc has to be reduced to NAc-muraminitol. Therefore, add 50 ml of reduction solution (10 mg/ml sodium borohydrate in 0.5 M borax in ddH 2 O at pH 9.0; both reagents were purchased from Merck) and incubate the sample for 20 minutes at room temperature. Stop the reaction with 10 ml phosphoric acid ( Afterwards, resuspend each pellet in 150 ml ddH 2 O. Close the wells carefully with a foil coverage (NOT lid), so that no water can ingress to the sample. Place the plate to a sonifier waterbath for 30 minutes (plate floats). Spin down the suspension (10 min at 4,700 rpm) and resuspend each pellet in 100 ml of solution B (15 mg/ml DNase and 60 mg/ml RNase in 0.1 M TRIS/HCl, pH 6.8). Properly close plate with foil coverage and incubate for 60 minutes at 37uC in a shaker at 150 rpm. It is better to place samples at the edge of the shaker than in the middle. Add 100 ml of solution C (50 mg/ ml trypsin in ddH 2 O), properly close plate with foil coverage and incubate for another 60 minutes at 37uC in a shaker at 150 rpm. To inactivate the enzymes boil the suspension for 5 minutes at 100uC. Spin down the suspension (10 min at 4,700 rpm) and wash each pellet once with 200 ml ddH 2 O. To release WTA resuspend each pellet in 200 ml of 1 M HCl (ready-to-use solution from Applichem) and incubate for 4 h at 37uC in a shaker (150 rpm, with foil coverage). Spin down the suspension (10 min at 4,700 rpm) and wash pellets with ddH 2 O until the pH is 5-6. Resuspend each pellet in 50 ml digestion buffer (12.5 mM sodium dihydrogen-phosphate, pH 5.5) and add 5 ml mutanolysin solution (5.000 U/ml of mutanolysin in ddH 2 O). Incubate the well plate for 16 h at 37uC (at 150 rpm, with foil coverage). Boil the samples on the heating block (100uC) for 5 minutes to inactivate mutanolysin. Afterwards spin the plate down (10 min at 4,700 rpm) and use the supernatant. Before applying the samples to the UPLC system, MurNAc has to be reduced to NAc-muraminitol. Add 10 ml of the reduction solution (10 mg/ml sodium borohydrate in 0.5 M borax in ddH 2 O at pH 9.0; both reagents were purchased from Merck) to each sample and incubate for 20 min at room temperature. [D CRITICAL STEP 2: The reduction solution contains a lot of bubbles. Transfer of the exact volume of 10 ml reduction solution is not possible. Set your pipette to a volume of 100 ml and add 1 drop to each sample. This accords to the needed volume.] Stop the reaction with 5 ml phosphoric acid (50%). The pH must be between 2 and 3 (add phosphoric acid very slow and carefully!). Then analyze the samples by UPLC or UPLC/MS. UPLC/MS ANALYSIS. An Acquity UPLC was coupled to a SynaptG2 mass spectrometer (both Waters). We used a C18 CSH 130Å , 1.7 mm, 2.1 mm 3 100 mm column with the respective guard column (C18 CSH 130Å , 1.7 mm, 2.1 mm 3 5 mm) available at Waters. As MS standard L-Enk was used.
The column temperature was 52uC and the injection volume was 10 ml with no loop overfill. Muropeptides were detected at 210 nm (DAD) or by MS. The MS was set to positive ESI mode with a scan range from 50-2,000. The capillary voltage was 3 kV. The sampling cone was set to 30 and the extraction cone to 3.0. Source temperature was set to 120uC and desolvation temperature to 450uC. The flow of the cone gas was 10 l/h and of the desolvation gas 800 l/h.
For muropeptide separation by UPLC/MS we used solvent A (0.1% TFA in 5% methanol; for Gram-negatives omit methanol) and solvent B (0.1% TFA in 30% methanol). TFA (trifluoroacetic acid) was bought from Carl Roth, methanol (UV grade) from Sigma-Aldrich. We applied a flow rate of 0.176 ml/min starting with 100% solvent A for 1 min. Afterwards, a linear gradient was run in 59 min to 100% solvent B. The post run was 5 min with 100% solvent B and additional 10 min with 100% solvent A for re-equilibration. [D CRITICAL STEP: A long and intensive equilibration of the column and an exact column temperature is very important. 
